Pegasus Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,226
| Closed | -$212K | – | 124 |
|
|
2022
Q2 | $212K | Hold |
2,226
| – | – | 0.04% | 113 |
|
|
2022
Q1 | $262K | Hold |
2,226
| – | – | 0.05% | 108 |
|
|
2021
Q4 | $288K | Hold |
2,226
| – | – | 0.05% | 118 |
|
|
2021
Q3 | $252K | Sell |
2,226
-39
| -2% | -$4.42K | 0.05% | 139 |
|
|
2021
Q2 | $235K | Buy |
+2,265
| New | +$235K | 0.05% | 150 |
|
|
2021
Q1 | – | Sell |
-2,265
| Closed | -$207K | – | 165 |
|
|
2020
Q4 | $207K | Buy |
+2,265
| New | +$207K | 0.05% | 143 |
|
|
2019
Q1 | – | Sell |
-6,726
| Closed | -$343K | – | 139 |
|
|
2018
Q4 | $343K | Hold |
6,726
| – | – | 0.1% | 121 |
|
|
2018
Q3 | $390K | Hold |
6,726
| – | – | 0.09% | 119 |
|
|
2018
Q2 | $326K | Hold |
6,726
| – | – | 0.08% | 126 |
|
|
2018
Q1 | $313K | Hold |
6,726
| – | – | 0.07% | 125 |
|
|
2017
Q4 | $253K | Hold |
6,726
| – | – | 0.05% | 149 |
|
|
2017
Q3 | $245K | Buy |
6,726
+726
| +12% | +$26.4K | 0.06% | 147 |
|
|
2017
Q2 | $236K | Buy |
+6,000
| New | +$236K | 0.06% | 143 |
|
|
2016
Q4 | – | Sell |
-6,000
| Closed | -$241K | – | 113 |
|
|
2016
Q3 | $241K | Buy |
+6,000
| New | +$241K | 0.11% | 108 |
|